| In millions, except per share items | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 |
| Revenues | 94.8 | 92.0 | 86.4 | 78.0 | 83.3 | 71.3 | 69.3 | 100.5 |
| Revenue growth | 3.1% | 6.5% | 10.7% | -6.3% | 16.9% | 2.8% | -31.0% | |
| Cost of goods sold | 28.8 | 27.7 | 26.9 | 27.1 | 25.5 | 27.1 | 26.1 | 33.4 |
| Gross profit | 66.1 | 64.3 | 59.5 | 51.0 | 57.8 | 44.2 | 43.3 | 67.1 |
| Gross margin | 69.7% | 69.9% | 68.8% | 65.3% | 69.4% | 62.0% | 62.4% | 66.8% |
| Selling, general and administrative | | | | | 39.3 | 40.9 | 45.6 | 45.0 |
| Sales and marketing | 35.1 | 31.8 | 34.4 | 28.5 | | | | |
| Research and development | 16.2 | 12.2 | 14.0 | 10.3 | 9.5 | 10.4 | 12.0 | 10.2 |
| General and administrative | 18.4 | 16.1 | 18.5 | 15.7 | | | | |
| EBITA | -0.6 | 7.0 | -4.6 | -2.5 | 9.3 | -6.7 | -15.4 | 11.9 |
| EBITA margin | -0.7% | 7.6% | -5.3% | -3.2% | 11.2% | -9.5% | -22.2% | 11.8% |
| Amortization of intangibles | 3.0 | 3.2 | 3.7 | 1.7 | 0.7 | 1.2 | 5.0 | 1.7 |
| EBIT | -3.6 | 3.8 | -8.2 | -4.2 | 8.7 | -7.9 | -20.4 | 10.1 |
| EBIT margin | -3.8% | 4.2% | -9.5% | -5.3% | 10.4% | -11.1% | -29.4% | 10.1% |
| Pre-tax income | -1.3 | 5.8 | -7.3 | -3.2 | 9.9 | -13.3 | -20.2 | 15.8 |
| Income taxes | -1.5 | 1.8 | -3.3 | -2.7 | 3.7 | -6.0 | -6.8 | 5.1 |
| Tax rate | 117.6% | 31.4% | 45.2% | 83.1% | 37.2% | 45.5% | 33.8% | 32.2% |
| Earnings from continuing ops | 0.2 | 4.0 | -4.0 | -0.5 | 6.2 | -7.2 | -13.4 | 10.7 |
| Earnings from discontinued ops | 0.0 | 0.0 | 0.0 | 0.1 | 12.5 | | | |
| Net income | 0.2 | 4.0 | -4.0 | -0.4 | 18.8 | -7.4 | -12.0 | 10.7 |
| Net margin | 0.2% | 4.3% | -4.7% | -0.6% | 22.5% | -10.4% | -17.2% | 10.6% |
| |
| Diluted EPS | $0.01 | $0.15 | ($0.14) | ($17.28) | $196.88 | ($226.99) | ($0.41) | $346.17 |
| Shares outstanding (diluted) | 24.3 | 27.1 | 29.1 | 0.0 | 0.0 | 0.0 | 32.3 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |